
Pfizer expects $26 billion in 2021 sales from COVID vaccine
NY Post
Pfizer said Tuesday it expects to do $26 billion in sales this year from its two-shot COVID-19 vaccine alone.
That’s up more than 70 percent from its last forecast, largely thanks to new contracts signed with countries struggling to get their hands on vaccine doses. The estimate assumes that Pfizer will deliver 1.6 billion doses of its COVID-19 vaccine in 2021. Across all of its products, Pfizer said in its first-quarter earnings report that it expects to make between $70.5 billion and $72.5 billion in revenue this year.More Related News

Gas prices reach highest level since October 2023 as oil holds above $100 per barrel; US stocks jump
Brent crude oil held above $100 per barrel on Monday, pushing national average gasoline prices to their highest level since October 2023 as President Trump urged allies to help protect oil tankers from Iranian attacks in the key Strait of Hormuz.












